VB Spine Expands Augmented Reality Navigation with CT-Fluoro Acquisition
Event summary
- VB Spine acquires exclusive rights to Augmedics’ CT-to-fluoroscopy (CT-Fluoro) technology for spine applications.
- The deal follows VB Spine’s April acquisition of the xvision Spine System® platform from Augmedics.
- CT-Fluoro allows surgeons to register preoperative CT scans using standard fluoroscopic imaging, potentially eliminating intraoperative CT or 3D imaging systems.
- Transaction terms were not disclosed; closing is subject to customary conditions and regulatory requirements.
The big picture
VB Spine’s acquisition of CT-Fluoro technology underscores its strategy of consolidating and enhancing augmented reality navigation tools for spine surgery. The move aligns with broader industry trends toward reducing procedural complexity and expanding access to advanced surgical technologies, particularly in cost-sensitive healthcare environments.
What we're watching
- Technology Integration
- How VB Spine will integrate CT-Fluoro into its existing xvision platform and the pace of adoption among surgeons.
- Market Expansion
- Whether this acquisition will help VB Spine penetrate new surgical settings or facilities with limited imaging capabilities.
- Competitive Dynamics
- How rival spine technology providers may respond to VB Spine’s enhanced augmented reality navigation offerings.
Related topics